Your browser doesn't support javascript.
loading
Progression of valvular calcification and risk of incident stroke: The Multi-Ethnic Study of Atherosclerosis (MESA).
Fashanu, Oluwaseun E; Bizanti, Anas; Al-Abdouh, Ahmad; Zhao, Di; Budoff, Matthew J; Thomas, Isac C; Longstreth, W T; Michos, Erin D.
Affiliation
  • Fashanu OE; Department of Medicine, Saint Agnes Hospital, Baltimore, MD, USA; Division of Cardiology, The Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address: oluwaseun.fashanu@ascension.org.
  • Bizanti A; Department of Medicine, Saint Agnes Hospital, Baltimore, MD, USA.
  • Al-Abdouh A; Department of Medicine, Saint Agnes Hospital, Baltimore, MD, USA.
  • Zhao D; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Budoff MJ; Lundquist Institute, Torrance, CA, USA.
  • Thomas IC; Division of Cardiology, University of California San Diego, San Diego, CA, USA.
  • Longstreth WT; Department of Neurology, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA.
  • Michos ED; Division of Cardiology, The Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins School of Medicine, Baltimore, MD, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Atherosclerosis ; 307: 32-38, 2020 08.
Article in En | MEDLINE | ID: mdl-32738574
BACKGROUND AND AIMS: Prevalent valvular calcification (VC) is associated with stroke but little is known about associations of VC progression with stroke. METHODS: Progression (interval increase >0 Agatston units/year) of aortic valvular calcification (AVC) and mitral annular calcification (MAC) was assessed by two cardiac CTs over a median of 2.4 years. We determined the risk of adjudicated total and ischemic stroke using Cox regression adjusted for cardiovascular disease (CVD) risk factors. RESULTS: We studied 5,539 MESA participants free of baseline CVD and atrial fibrillation. Baseline mean ± SD age was 62 ± 10 years; 53% were women; 83% had no progression of VC; 15%, progression at one site (AVC or MAC), and 3%, progression at both sites. Over a median of 12 years, 211 total and 167 ischemic strokes occurred. The number of sites with VC progression (range 0-2) was not associated with total and ischemic stroke (all p > 0.05). We found MAC progression to be associated with increased risk of total stroke [adjusted hazard ratio (95% CI) 1.59 (1.11, 2.28)] and ischemic stroke [1.64 (1.10, 2.45)]. Results remained significant after further adjustment for baseline coronary artery calcification. After excluding participants with interim atrial fibrillation and coronary heart disease, findings were no longer statistically significant in fully-adjusted models. There was no interaction by age, sex, or race/ethnicity. There was no association with AVC progression and stroke. CONCLUSIONS: Progression of MAC but not AVC over 2.4 years is associated with increased risk of total and ischemic stroke.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aortic Valve Stenosis / Calcinosis / Atherosclerosis / Heart Valve Diseases Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Atherosclerosis Year: 2020 Document type: Article Country of publication: Ireland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aortic Valve Stenosis / Calcinosis / Atherosclerosis / Heart Valve Diseases Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Atherosclerosis Year: 2020 Document type: Article Country of publication: Ireland